Autologous Transplantation in First Complete Remission
Despite recent and ongoing studies in which autologous transplants are an integral part of 'standard' therapy, there is no convincing data demonstrating superior survival compared with appropriate post-remission chemotherapy or allogeneic transplant in any circumstance.[42,43,46] In addition, autologous transplantation in first remission may prevent or increase the risk of later allotransplantation in patients who relapse. While it is reasonable to study autotransplant in selected patients in first remission, its routine use is not justified.
Future Oncol. 2009;5(4):559-568. © 2009 Future Medicine Ltd.
Cite this: Treatment of Acute Myeloid Leukemia With Hematopoietic Stem Cell Transplantation - Medscape - May 01, 2009.